Grund Nicholas 4
4 · Akebia Therapeutics, Inc. · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
Akebia (AKBA) CCO Nicholas Grund Receives RSUs & Options
What Happened
Nicholas Grund, Chief Commercial Officer of Akebia Therapeutics (AKBA), received equity awards on January 30, 2026: 204,000 restricted stock units (RSUs) and 320,000 derivative awards (stock options), both reported at $0. These are grants/awards (transaction code A) — compensation, not open-market purchases or sales.
Key Details
- Transaction date: 2026-01-30; Form 4 filed 2026-02-03 (filed within the SEC’s two-business-day window).
- Awards reported: 204,000 RSUs (reported acquisition value $0) and 320,000 derivative awards/options (reported $0).
- Shares owned after transaction: not specified in the provided Form 4 summary.
- Footnotes:
- RSU vesting (F1): granted under the 2023 Stock Incentive Plan; vesting in three equal annual installments (one-third each year) subject to continued service.
- Options vesting (F2): granted under the 2023 Stock Incentive Plan; vest over four years — 25% at the first anniversary, then remaining 75% in equal quarterly installments, subject to continued service.
- No exercise or sale occurred; these are grant awards (not cashless exercises or market sales).
Context
Grants like RSUs and options are common executive compensation and don’t represent an immediate buy or sell of shares. Options are rights to purchase shares in the future (they’re not exercised here); RSUs convert to shares as they vest. Because the filing does not show an exercise price or immediate sale, there is no immediate cash flow or change in public float from these entries.
Insider Transaction Report
- Award
Common Stock
[F1]2026-01-30+204,000→ 646,579 total - Award
Stock Option (Right to buy)
[F2]2026-01-30+320,000→ 320,000 totalExercise: $1.41Exp: 2036-01-30→ Common Stock (320,000 underlying)
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.